Skip to main content
Urinary Tract InfectionNewbornChildren's healthDrugPhase 4

What this study is

The goal of this smaller clinical trial is to evaluate the study design of this research to help prepare for a larger research study in the future. The future larger study would focus on whether steroid cream can reduce recurrent urinary tract infections in male infants, who are not circumcised.

Male infants, who are enrolled in this study, would receive either the steroid cream or a placebo cream (a look alike cream without steroids). The cream would be applied twice a week for four weeks. Then there would be two follow up visits with the research team to measure whether the infant experienced any urinary tract infections and to measure parent perceptions of their experience participating in the study.

What's being tested

  • betamethasone valerate 0.1% cream

    Intervention · DRUG

    Steroid cream applied to the foreskin and glans twice a day for four weeks.

  • Placebo cream

    Intervention · DRUG

    Placebo cream is applied to the foreskin and glans twice a day for four weeks.

Study details

Official title
Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants With a First Febrile Urinary Tract Infection: a Multi-center Pilot Study
Sponsor
Baylor College of Medicine
Conditions
Urinary Tract Infection
Enrolling
40 people
Starts
2026-04
Est. completion
2027-12
Design
Quadruple-blind, randomized, parallel groups, Phase 4
Record
View on ClinicalTrials.gov ↗